Intel’s stock looks bearish 📉, with the 9-day EMA dipping below the 21-day, signaling short-term weakness. RSI at 44 is neutral but trending down from 50, hinting at fading momentum. Volume spikes on down days suggest selling pressure. News is mixed—Altera stake sale could help, but tariffs and earnings risks loom. No clear reversal pattern yet; wait for RSI to hit oversold (<30) or a bullish crossover in EMAs before considering a buy. Hold for now, but watch closely! 🔍

Intel's stock shows mixed signals 📊. The 9-day EMA is below the 21-day, hinting at short-term weakness, but RSI (~57) is neutral, avoiding overbought/oversold extremes. Volume spiked on 4/25, suggesting strong interest, but recent dips lack conviction. News highlights Intel’s tech wins (18A process, AI partnerships) but also skepticism about its turnaround. Chart shows volatility with no clear pattern. Hold for now—wait for a breakout above $21 or breakdown below $19.50. 🧐 #PatiencePays

Intel Corporation engages in the design, manufacture, and sale of computer products and technologies worldwide. The company operates through CCG, DCG, IOTG, Mobileye, NSG, PSG, and All Other segments. It offers platform products, such as central processing units and chipsets, and system-on-chip and multichip packages; and non-platform or adjacent products, including accelerators, boards and systems, connectivity products, graphics, and memory and storage products. The company also provides high-performance compute solutions for targeted verticals and embedded applications for retail, industrial, and healthcare markets; and solutions for assisted and autonomous driving comprising compute platforms, computer vision and machine learning-based sensing, mapping and localization, driving policy, and active sensors. In addition, it offers workload-optimized platforms and related products for cloud service providers, enterprise and government, and communications service providers. The company serves original equipment manufacturers, original design manufacturers, and cloud service providers. Intel Corporation has a strategic partnership with MILA to develop and apply advances in artificial intelligence methods for enhancing the search in the space of drugs. The company was incorporated in 1968 and is headquartered in Santa Clara, California.

Intel Corporation INTC: 20.885 USD

Bullish views

Bearish views